Dr Reddy's Laboratories Ltd
F:RDDA
Wall Street
Price Targets
RDDA Price Targets Summary
Dr Reddy's Laboratories Ltd
According to Wall Street analysts, the average 1-year price target for
RDDA
is 13.09 EUR
with a low forecast of 9.97 EUR and a high forecast of 16.35 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is RDDA's stock price target?
Price Target
13.09
EUR
According to Wall Street analysts, the average 1-year price target for
RDDA
is 13.09 EUR
with a low forecast of 9.97 EUR and a high forecast of 16.35 EUR.
What is Dr Reddy's Laboratories Ltd's Revenue forecast?
Projected CAGR
6%
For the last 13 years the
compound annual growth rate for
Dr Reddy's Laboratories Ltd's revenue is
10%.
The projected
CAGR
for the next 3 years is
6%.
What is Dr Reddy's Laboratories Ltd's Operating Income forecast?
Projected CAGR
-2%
For the last 13 years the
compound annual growth rate for
Dr Reddy's Laboratories Ltd's operating income is
10%.
The projected
CAGR
for the next 3 years is
-2%.
What is Dr Reddy's Laboratories Ltd's Net Income forecast?
Projected CAGR
-1%
For the last 13 years the
compound annual growth rate for
Dr Reddy's Laboratories Ltd's net income is
12%.
The projected
CAGR
for the next 3 years is
-1%.
